Kura Oncology, Inc. News
Tesla, Dunkin Brands, Lam Research: 'Mad Money' Lightning Round
Jim Cramer weighs in on Tesla, Dunkin Brands, Lam Research, Marvell Technology, Kura Oncology, Netease, Ulta Beauty, CareDX and more.
Kura Oncology Soars After Lymphoma Treatment Test Results
Kura Oncology climbs after the clinical-stage biopharmaceutical company says a phase 2 trial of its lymphoma treatment tipifarnib showed encouraging results.
Moleculin Biotech gets good verbal OK from FDA which should cut time to phase 1/2 trial down
The Texas-based biotech raised just $9 million in an unorthodox IPO earlier this year, but FDA move should slice months off the time it takes to complete phase 2 trials.
These 7 stocks under $10 are making big moves higher. Here's how to trade them now.
When a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits.
Costco Beats Q3 Sales Forecast, Membership Revenues Near $1 Billion
Costco took in $984 million in new membership fee in its fiscal third quarter, helping the bulk retailer top Street forecasts for topline revenues.
Gap Stock Plummets On Wider Q1 Loss, Grim Profit Outlook As Shoppers Shun Casual Apparel
"Supply chain challenges and persistent delays significantly limited the brand's responsive abilities" to changing consumer trends, CEO Sonia Syngal told investors Thursday.
Big Lots Stock Crumbles After Surprise Q1 Loss As Inflation, Gas Price Surge Bites Spending
"We believe the slowdown was caused by the spending pressure our consumers felt from higher gas prices and broader inflation," said CEO Bruce Thorn.
Broadcom Agrees to Buy VMware in $61 Billion Cash-and-Stock Cloud Software Deal
"Combining our assets and talented team with Broadcom's existing enterprise software portfolio creates a remarkable enterprise software player," said VMware CEO Raghu Raghuram.